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To the Editor:
The study by Masunaga et al in the August 1997 issue of the Journal of
Investigative Dermatology used purified IgG developed against a baculo-
virus-encoded recombinant of BPAG2 to localize the ectodomain of
this protein in human epidermal basement membrane. Re-evaluation
of the BPAG2 cDNA used in this study found that it contained a
single base substitution (C→T) resulting in a stop codon at nucleotide
4396 (GenBank accession number M91669). Hence, the baculovirus-
encoded recombinant used to develop BPAG2-specific IgG lacked 68
amino acids at the carboxyl terminus of this protein. Consequently,
our immunoelectron microscopy studies may have underestimated
how far the carboxyl terminus of BPAG2 extends into the lamina
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densa of human epidermal basement membrane. BPAG2 remains the
first molecule shown to extend from the cytoplasm of basal keratinocytes
to the lamina densa of epidermal basement membrane.
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